Parkinson's disease and Porphyromonas gingivalis levels

a case-control study

Authors

  • Nathália Alves Gusmão Universidade Federal de Minas Gerais, Faculdade de Odontologia
  • Augusto Paixão Moraes Mateus Universidade Federal de Minas Gerais, Faculdade de Odontologia
  • Victor Bento Oliveira Universidade Federal de Minas Gerais, Faculdade de Odontologia
  • Rafael Paschoal Esteves Lima Universidade Federal de Minas Gerais, Faculdade de Odontologia
  • José Roberto Cortelli University of Taubaté image/svg+xml
  • Sheila Cavalca Cortelli University of Taubaté image/svg+xml
  • Fernando Oliveira Costa Universidade Federal de Minas Gerais, Faculdade de Odontologia

DOI:

https://doi.org/10.1590/1678-7765-2025-0780

Keywords:

Case-control study, Neurodegeneration, Parkinson’s disease, Periodontitis, Systemic inflammation, Porphyromonas gingivalis

Abstract

Neurodegenerative diseases have been associated with periodontal diseases. Objectives  This study aimed to evaluate the clinical and epidemiological aspects of the association between Parkinson's disease (PKD) and periodontitis (PE), including the quantification of Porphyromonas gingivalis and the influence of different risk variables on this association. Methodology  This case-control study included 172 individuals: 86 cases (PKD) and 86 controls (without any neurodegenerative disease). Participants underwent a complete periodontal examination (plaque index and probing depth), and clinical subgingival sampling was conducted to quantify Porphyromonas gingivalis counts. The association between PKD and PE was evaluated through univariate and binary logistic regression analyses. Results  A high prevalence of PE (73.2%) was observed among individuals with PKD [OR=3.99 (2.00-7.59); p<0.001]. Variables that were significantly retained in the final binary logistic regression model for the occurrence of PKD were: PE (OR=3.23; p=0.003), mean P. gingivalis counts (OR= 3.39; p=0.036), lower number of teeth (OR= 2.21, p<0.001), low frequency of toothbrushing/day (OR=1.95; p=0.006), and bleeding on probing (OR=2.45; p<0.001). The significant positive correlations observed between P. gingivalis counts and clinical periodontal parameters were considered moderate to strong in individuals with PKD. Conclusions  A strong association between PKD and PE was demonstrated, with risk increasing in parallel with the severity of periodontal involvement. Furthermore, individuals with PKD exhibited significantly higher levels of P. gingivalis compared to controls.

Downloads

Download data is not yet available.

References

1- Colombo APV, Magalhães CB, Hartenbach FA, Souto RM, Boghossian CM. Periodontal-disease-associated biofilm: a reservoir for pathogens of medical importance. Microb Pathog. 2016;94(5):27-34. doi: 10.1016/j.micpath.2015.09.009

» https://doi.org/10.1016/j.micpath.2015.09.009

2- Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Periodontol. 2018;89(S1):159-S172. doi: 10.1002/JPER.18-0006

» https://doi.org/10.1002/JPER.18-0006

3- Beck JC, Kasten M, Marsiske M, Atri A, Blennow K, Zetterberg H, et al. Cognitive decline in Parkinson's disease: a longitudinal study using video assessments. Mov Disord. 2016;31(5):658-65. doi:10.1002/mds.26498

» https://doi.org/10.1002/mds.26498

4- Di Monte DA. The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol. 2003;2(9):531-8. doi: 10.1016/s1474-4422(03)00501-5

» https://doi.org/10.1016/s1474-4422(03)00501-5

5- Einarsdóttir ER, Gunnsteinsdóttir H, Hallsdóttir MH, Jónsdóttir SR, Olafsson VG, Arnadóttir IB. Dental health of patients with Parkinson's disease in Iceland. Spec Care Dentist. 2009;29(3):123-7. doi: 10.1111/j.1754-4505.2009.00075.x

» https://doi.org/10.1111/j.1754-4505.2009.00075.x

6- El Choueiri E, El Choueiri J, El Choueiri A. Oral health as a modifiable risk factor for neurodegeneration: Prudent optimism and interdisciplinary action. J Clin Neurosci. 2025;29(138):111354. doi: 10.1016/j.jocn.2025.111354

» https://doi.org/10.1016/j.jocn.2025.111354

7- Balestrino R, Schapira AH. Parkinson disease. European J Neurol. 2020;227(1):27-42. doi: 10.1111/ene.14108

» https://doi.org/10.1111/ene.14108

8- Lee NE, Yoo DM, Han KM, Kang HS, Kim JH, Kim JH, et al. Investigating the connection between chronic periodontitis and Parkinson's disease: findings from a Korean National cohort study. Biomedicines. 2024;12(4):792. doi: 10.3390/biomedicines12040792

» https://doi.org/10.3390/biomedicines12040792

9- Hanaoka A, Kashihara K. Increased frequencies of caries, periodontal disease and tooth loss in patients with Parkinson's disease. J Clin Neurosci. 2009;16(10):1279-82. doi: 10.1016/j.jocn.2008.12.027

» https://doi.org/10.1016/j.jocn.2008.12.027

10- Botelho J, Lyra P, Proença L, Godinho C, Mendes JJ, Machado V. Relationship between blood and standard biochemistry levels with periodontitis in Parkinson's disease patients: data from the NHANES 2011-2012. J Pers Med. 2020;25(3):69. doi: 10.3390/jpm10030069

» https://doi.org/10.3390/jpm10030069

11- Lyra P, Botelho J, Machado V, Rota S, Walker R, Staunton J, et al. Self-reported periodontitis and C-reactive protein in Parkinson's disease: a cross-sectional study of two American cohorts. NPJ Parkinsons Dis. 2022;8(1):40. doi: 10.1038/s41531-022-00302-1

» https://doi.org/10.1038/s41531-022-00302-1

12- Visentin D, Gobin I, Maglica Z. Periodontal pathogens and their links to neuroinflammation and neurodegeneration. Microorganisms. 2023;(11):1832. doi: 10.3390/microorganisms11071832

» https://doi.org/10.3390/microorganisms11071832

13- Rozas NS, Tribble GD, Jeter CB. Oral factors that impact the oral microbiota in Parkinson's disease. Microorganisms. 2021;9(8):1616. doi: 10.3390/microorganisms9081616

» https://doi.org/10.3390/microorganisms9081616

14- Tribble GD, Kerr JE, Wang BY. Genetic diversity in the oral pathogen Porphyromonas gingivalis: molecular mechanisms and biological consequences. Future Microbiol. 2013;8(5):607-20. doi: 10.2217/fmb.13.30

» https://doi.org/10.2217/fmb.13.30

15- Zhang S, Yang F, Wang Z, Qian X, Ji Y, Gong L, et al. Poor oral health conditions and cognitive decline: studies in humans and rats. PLoS One. 2020;15(7):e0234659. doi: 10.1371/journal.pone.0234659

» https://doi.org/10.1371/journal.pone.0234659

16- Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30(12):1591-601. doi: 10.1002/mds.26424

» https://doi.org/10.1002/mds.26424

17- Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res. 1975;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6

» https://doi.org/10.1016/0022-3956(75)90026-6

18- Tomar SL, Asma S. Smoking-attributable periodontitis in the United States: findings From NHANES III. J Periodontol. 2000;71(5):743-51. doi: 10.1902/jop.2000.71.5.743

» https://doi.org/10.1902/jop.2000.71.5.743

19- American Diabetes Association. Classification and diagnosis of diabetes mellitus. Diabetes Care. 2015;(38):S8-S16. doi:10.2337/dc15-S005

» https://doi.org/10.2337/dc15-S005

20- Cortelli SC, Costa FO, Rodrigues E, Cota LO, Cortelli JR. Periodontal therapy effects on nitrite related to oral bacteria: a 6-month randomized clinical trial. J Periodontol. 2015;86(8):984-94. doi:10.1902/jop.2015.140678

» https://doi.org/10.1902/jop.2015.140678

21- Nazir M, Al-Ansari A, Al-Khalifa K, Alhareky M, Gaffar B, Almas K. Global prevalence of periodontal disease and lack of its surveillance. ScientificWorldJournal. 2020:2146160. doi: 10.1155/2020/2146160

» https://doi.org/10.1155/2020/2146160

22- Listl S, Galloway J, Mossey PA, Marcenes W. Global Economic Impact of Dental Diseases. J Dent Res. 2015;94(10):1355-136. doi: 10.1177/0022034515602879

» https://doi.org/10.1177/0022034515602879

23- Kaliamoorthy S, Nagarajan M, Sethuraman V, Jayavel K, Lakshmanan V, Palla S. Association of Alzheimer's disease and periodontitis - a systematic review and meta-analysis of evidence from observational studies. Med Pharm Rep. 2022;95(2):144-51. doi: 10.15386/mpr-2278

» https://doi.org/10.15386/mpr-2278

24- Gil-Montoya JA, Barrios R, Santana S, Sanchez-Lara I, Pardo CC, et al. Association between periodontitis and amyloid ß peptide in elderly people with and without cognitive impairment. J Periodontol. 2017;88(10):1051-8. doi: 10.1902/jop.2017.170071

» https://doi.org/10.1902/jop.2017.170071

25- Chen CK, Wu YT, Chang YC. Periodontal inflammatory disease is associated with the risk of Parkinson's disease: a population-based retrospective matched-cohort study. Peer J. 2017;10(5):e3647. doi: 10.7717/peerj.3647

» https://doi.org/10.7717/peerj.3647

26- Holmer J, Eriksdotter M, Häbel H, Hed Myrberg I, Jonsson A, Pussinen PJ, et al. Periodontal conditions and incident dementia: a nationwide Swedish cohort study. J Periodontol. 2022;93(9):1378-86. doi: 10.1002/jper.21-0518

» https://doi.org/10.1002/jper.21-0518

27- Syrjälä AM, Ylöstalo P, Ruoppi P, Komulainen K, Hartikainen S, Sulkava R, et al. Dementia and oral health among subjects aged 75 years or older. Gerodontology. 2012;29(1):36-42. doi: 10.1111/j.1741-2358.2010.00396.x

» https://doi.org/10.1111/j.1741-2358.2010.00396.x

28- García-de-la-Fuente AM, Fernández-Jiménez A, Lafuente-Ibáñez-de-Mendoza I, Lartitegui-Sebastián MJ, Marichalar-Mendia X, Aguirre-Urizar JM. Periodontal health in a population with Parkinson's disease in Spain: a cross-sectional study. Med Oral Patol Oral Cir Bucal. 2020;25(1):e1-e7. doi:10.4317/medoral.25540

» https://doi.org/10.4317/medoral.25540

29- Demmer RT, Norby FL, Lakshminarayan K, Walker KA, Pankow JS, Folsom AR, et al. Periodontal disease and incident dementia: the Atherosclerosis Risk in Communities Study (ARIC). Neurology. 2020;95(12):e1660-e1671. doi: 10.1212/WNL.0000000000010312

» https://doi.org/10.1212/WNL.0000000000010312

30- Pardo A, Barilli A, Signoriello A. Oral health conditions and hygiene procedures in patients with Parkinson's disease: a systematic review. Explor Med. 2024;5(6):852-69. doi: 10.37349/emed.2024.00260

» https://doi.org/10.37349/emed.2024.00260

31- Qiu X, Zhang R, Cheng Y, Jin C, Zhang Y, Zhang Z. Oral health implications in Parkinson's disease. NPJ Parkinson's Dis. 2025;11(1):1-9. doi:10.1038/s41531-025-00927-y

» https://doi.org/10.1038/s41531-025-00927-y

32- Rozas NS, Tribble GD, Jeter CB. Oral factors that impact the oral microbiota in Parkinson's disease. Microorganisms. 2021;9(8):1616. doi: 10.3390/microorganisms9081616

» https://doi.org/10.3390/microorganisms9081616

33- Carrasco L, Pisa D, Alonso R. Polymicrobial infections and neurodegenerative diseases. Curr Clin Micro Rept. 2020;(7):20-30. doi: 10.1007/s40588-020-00139-3

» https://doi.org/10.1007/s40588-020-00139-3

34- Ermini F, Low VF, Song JJ, Tan AY, Faull RL, Dragunow M, et al. Ultrastructural localization of Porphyromonas gingivalis gingipains in the substantia nigra of Parkinson's disease brains. NPJ Parkinsons Dis. 2024;25;10(1):90. doi: 10.1038/s41531-024-00705-2

» https://doi.org/10.1038/s41531-024-00705-2

35- Li D, Ren T, Li H, Liu H, Xu R, Huang M, et al. Oral microbiota and Porphyromonas gingivalis Kgp genotypes altered in Parkinson's disease with mild cognitive impairment. Mol Neurobiol. 2024;61(11):8631-9. doi: 10.1007/s12035-024-04119-2

» https://doi.org/10.1007/s12035-024-04119-2

36- Verhoeff MC, Koutris M, Vries RD, Berendse HW, Dijk KD, Lobbezoo F. Salivation in Parkinson's disease: a scoping review. Gerodontology. 2023;40(1):26-38. doi: 10.1111/ger.12628

» https://doi.org/10.1111/ger.12628

37- Liu Z, Roosaar A, Axéll T, Ye W. Tobacco use, oral health, and risk of Parkinson's disease. Am J Epidemiol. 2017;185(7):538-45. doi: 10.1093/aje/kww146

» https://doi.org/10.1093/aje/kww146

38- Bakke M, Larsen SL, Lautrup C, Karlsborg M. Orofacial function and oral health in patients with Parkinson's disease. Eur J Oral Sci. 2011;119(1):27-32. doi: 10.1111/j.1600-0722.2010.00802.x

» https://doi.org/10.1111/j.1600-0722.2010.00802.x

39- Thomson WM, Barak Y. Tooth loss and dementia: a critical examination. J Dent Res. 2021;100(3):226-31. doi: 10.1177/0022034520957233

» https://doi.org/10.1177/0022034520957233

40- Herrera D, Sanz M, Shapira L, Brotons C, Chapple I, Frese T, et al. Periodontal diseases and cardiovascular diseases, diabetes, and respiratory diseases: summary of the consensus report by the European Federation of Periodontology and WONCA Europe. Eur J Gen Pract. 2024;30(1):2320120. doi: 10.1080/13814788.2024.2320120

» https://doi.org/10.1080/13814788.2024.2320120

Downloads

Published

2026-03-23

Issue

Section

Original Articles

How to Cite

Gusmão, N. A., Mateus, A. P. M., Oliveira, V. B., Lima, R. P. E., Cortelli, J. R., Cortelli, S. C., & Costa, F. O. (2026). Parkinson’s disease and Porphyromonas gingivalis levels: a case-control study. Journal of Applied Oral Science, 34, e2025-0780. https://doi.org/10.1590/1678-7765-2025-0780